Cargando…

Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study

Parkinson’s disease (PD) is characterized by motor symptoms often experienced in concomitance with non-motor symptoms (NMS), such as depression, apathy, pain, sleep disorders, and urinary dysfunction. The present study aimed to explore the effect of safinamide treatment on NMS and quality of life in...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Masi, Claudia, Liguori, Claudio, Spanetta, Matteo, Fernandes, Mariana, Cerroni, Rocco, Garasto, Elena, Pierantozzi, Mariangela, Mercuri, Nicola Biagio, Stefani, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2022
Materias:	Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550691/ https://www.ncbi.nlm.nih.gov/pubmed/36070008 http://dx.doi.org/10.1007/s00702-022-02538-w

Ejemplares similares

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG
por: Conti, Matteo, et al.
Publicado: (2022)

Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study
por: Carpi, Matteo, et al.
Publicado: (2023)

Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
por: Pauletti, Caterina, et al.
Publicado: (2023)

Sustained response in early responders to safinamide in patients with Parkinson's disease and motor fluctuations: A post hoc analysis of the SETTLE study
por: Bhidayasiri, Roongroj, et al.
Publicado: (2023)

Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
por: Liguori, Claudio, et al.
Publicado: (2022)

Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study
por: Gnarra, Oriella, et al.
Publicado: (2023)

Gender differences in non-motor fluctuations in Parkinson’s disease
por: Donzuso, Giulia, et al.
Publicado: (2023)

Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations
por: Takeda, Atsushi, et al.
Publicado: (2021)

Efficacy of Safinamide and Gender Differences During Routine Clinical Practice
por: Pellecchia, Maria T., et al.
Publicado: (2021)

The Efficacy of Safinamide in the Management of Parkinson's Disease: A Systematic Review
por: Sharaf, Joudi, et al.
Publicado: (2022)

Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2021)

Impact of non-motor fluctuations on QOL in patients with Parkinson’s disease
por: Kakimoto, Asako, et al.
Publicado: (2023)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
por: Cerroni, Rocco, et al.
Publicado: (2020)

STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson’s Disease
por: Conti, Matteo, et al.
Publicado: (2022)

Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease
por: Sisto, Renata, et al.
Publicado: (2020)

Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
por: Borgohain, Rupam, et al.
Publicado: (2014)

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease
por: Kulisevsky, Jaime, et al.
Publicado: (2022)

Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?
por: Stefani, Alessandro, et al.
Publicado: (2022)

Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
por: Hattori, Nobutaka, et al.
Publicado: (2022)

Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
por: Schirinzi, Tommaso, et al.
Publicado: (2019)

Motor and non-motor improvements following short-term multidisciplinary day-clinic care in Parkinson´s disease
por: Krause, Patricia, et al.
Publicado: (2022)

Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis
por: Suppa, Antonio, et al.
Publicado: (2023)

Sleep and non-motor symptoms in Parkinson’s disease
por: Maass, Antonia, et al.
Publicado: (2013)

Oculomotor Performances Are Associated With Motor and Non-motor Symptoms in Parkinson's Disease
por: Zhang, Yu, et al.
Publicado: (2018)

Non-motor symptoms of Parkinson’s disease: the patient’s perspective
por: Breen, Kieran C., et al.
Publicado: (2012)

Interrater reliability of motor severity scales for hemifacial spasm
por: Lee, Ha Yeon, et al.
Publicado: (2023)

Music Therapy Alleviates Motor Dysfunction in Rats With Focal Cerebral Ischemia–Reperfusion Injury by Regulating BDNF Expression
por: Chen, Weiguan, et al.
Publicado: (2021)

The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Post-hoc Analysis of a Japanese Phase 2/3 Study
por: Hattori, Nobutaka, et al.
Publicado: (2022)

Mapping of the Motor Cortex
por: Jahangiri, Faisal R, et al.
Publicado: (2020)

Does Resting Motor Threshold Predict Motor Hand Recovery After Stroke?
por: Rosso, Charlotte, et al.
Publicado: (2018)

Shaping the Sensory–Motor Network by Short-Term Unresolvable Sensory–Motor Mismatch
por: Klingner, Carsten M., et al.
Publicado: (2022)

Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson’s Disease
por: Cerroni, Rocco, et al.
Publicado: (2022)

The Cortical Lesion for Motor Aphasia
Publicado: (1909)

Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
por: Chaudhuri, K. Ray, et al.
Publicado: (2013)

Hedonicity in functional motor disorders: a chemosensory study assessing taste
por: Cecchini, Maria Paola, et al.
Publicado: (2020)

Hyposmia as a marker of (non-)motor disease severity in Parkinson’s disease
por: Roos, Dareia S., et al.
Publicado: (2019)

Abnormal cerebellum connectivity patterns related to motor subtypes of Parkinson’s disease
por: Chen, Zhenzhen, et al.
Publicado: (2023)

The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
por: Rocha, José-Francisco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_763q3t49gduq1jansq5o6bs4n6